Insider Transactions Reported by 53 Insiders of Keenova Therapeutics plc

Location
Dublin 15

Insiders trading volume in the past year

Keenova Therapeutics plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
GOLDENTREE ASSET MANAGEMENT LP 10%+ Owner $735,021,280 +$7,562,250 +1% 04 Aug 2025
Silver Point Capital L.P. 10%+ Owner $417,365,867 +$44,854,943 +12% 08 Dec 2025
Alta Fundamental Advisers LLC 10%+ Owner $73,015,988 16 Jun 2023
Sigurdur O. Olafsson President and CEO, Director $2,814,973 01 Jan 2026
Christiana Stamoulis President and CFO $1,582,235 19 Dec 2025
David J. Stetson Director $1,001,497 31 Jul 2025
Wesley Wheeler Director $869,585 31 Jul 2025
Abbas Hussain Director $846,230 31 Jul 2025
Paul Efron Director $781,319 14 Aug 2025
Lisa French EVP & Chief Commercial Officer $744,613 01 Jan 2026
Mark Tyndall EVP & CLO and Corp Sec $724,821 01 Jan 2026
Jon Zinman Director $712,751 01 Jan 2026
Henriette Nielsen EVP & Chief Transformation OFC $668,998 01 Jan 2026
Mark T. Bradley EVP, Chief Integration Officer $371,431 31 Jul 2025
Paul Bisaro Director $370,798 01 Jan 2026
Katina Dorton Director $222,319 01 Jan 2026
Hugh Paul ONeill EVP, Qual & Ops, Spec Brands $159,928 01 Jan 2026
Sophia D. Langlois Director $68,768 14 Aug 2025
Marc J. Yoskowitz Director $68,076 20 Oct 2025
Tracy Basso Evp & Chro $67,643 31 Jul 2025
Susan Ann Williamson EVP & Chief Compliance Officer $62,799 31 Jul 2025
Cheryl Ann Stouch EVP & Chief Info Officer $54,582 31 Jul 2025
Scott Hirsch Director $39,358 14 Aug 2025
DR KNEELAND YOUNGBLOOD Director 16 Jun 2022
J. MARTIN CARROLL Director 16 Jun 2022
Carlos V. Paya Director 16 Jun 2022
DAVID R. CARLUCCI Director 16 Jun 2022
Leslie E. Donato Director 14 Aug 2025
Frank B. Raciti Controller & CAO 19 Aug 2025
Marek Honczarenko EVP & Chief Scientific Officer 29 Sep 2025
David Norton Director 16 Jun 2022
Peter C. Richardson EVP & Chief Scientific Officer 31 Jul 2025
Karen Ling Director 14 Nov 2023
Bracebridge Capital, LLC 10%+ Owner 14 Nov 2023
IAN J. WATKINS EVP & Chief Human Resources Officer 16 Jun 2022
JAMES R. SULAT Director 14 Nov 2023
WOODROW A. MYERS JR Director 14 Nov 2023
Mark Trudeau President and CEO, Director 16 Jun 2022
JOANN A. REED Director 16 Jun 2022
Casey Mark J EVP & Chief Legal Officer 16 Jun 2022
Bryan M. Reasons Evp & Cfo 31 Jul 2025
Jason Daniel Goodson EVP & Chief Strategy Officer 01 Jan 2025
Kassie Harrold EVP & Chief Compliance Officer 01 Jan 2025
Hugh M. O'Neill EVP & Chief Comm and Ops Ofcr 16 Jun 2022
Steven J. Romano EVP & Chief Sci. Ofcr 16 Jun 2022
Paul Rutherford Carter Director 16 Jun 2022
Daniel Arthur Celentano Director 14 Nov 2023
Riad El-Dada Director 14 Nov 2023
Stephen Andrew Welch EVP & Head of Spec Generics 10 Nov 2025
Angus C. Russell Director 16 Jun 2022
NEAL P. GOLDMAN Director 14 Nov 2023
Susan Silbermann Director 14 Nov 2023
Anne Clem Whitaker Director 16 Jun 2022

Recent Insider Transactions by Companies or Individuals for Keenova Therapeutics plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.